https://www.mayoclinic.org/es/drugs-supplements/lazertinib-oral-route/description/drg-20573799
Lazertinib (oral route) - Side effects & dosage - Mayo Clinic
side effectslazertiniboralroutedosage
https://www.jnj.com/innovativemedicine/emea/janssen-announces-new-data-supporting-safety-profile-and-efficacy-amivantamab-and-lazertinib-0
Janssen Announces New Data Supporting Safety Profile and Efficacy of Amivantamab and Lazertinib...
new datasafety profile
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lazertinib-amivantamab-vmjw-non-small-lung-cancer
FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer | FDA
On August 19, 2024, the FDA approved lazertinib (Lazcluze, Janssen Biotech, Inc.) in combination with amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) for...
fda approveslazertinibamivantamab